Age (years) | 61.9±7.8 | 58.5±7.1 | 0.003 |
Male sex, n (%) | 51 (62.1) | 47 (57.3) | 0.289 |
BMI (kg/m2) | 27.89±2.2 | 27.6±2.1 | 0.407 |
Hypertension, n (%) | 36 (43.9) | 22 (26.8) | 0.034 |
Diabetes mellitus, n (%) | 16 (19.5) | 15 (18.3) | 1.000 |
Smoking, n (%) | 49 (59.8) | 36 (43.9) | 0.061 |
Heart rate (bpm) | 73.4±10.6 | 70.6±9.6 | 0.086 |
Systolic blood pressure (mm Hg) | 125.1±14.2 | 121.2±12.3 | 0.066 |
Diastolic blood pressure (mm Hg) | 79±10.5 | 75±9.1 | 0.022 |
White cell count (×103/mm3) | 11.42±4.1 | 11.1±5.17 | 0.449 |
Hemoglobin (g/dL) | 14.34±1.4 | 14.05±1.7 | 0.231 |
Platelet (×103/mm3) | 244.41±48.3 | 234.04±60.3 | 0.066 |
Serum glucose (mg/dL) | 108.72±28.9 | 109.79±39.7 | 0.234 |
Serum creatinine (mg/dL) | 0.9±0.2 | 0.85±0.2 | 0.120 |
HbA1C (%) | 5.4±1.1 | 5.2±0.9 | 0.456 |
Triglyceride (mg/dL) | 176.16±129.4 | 171.49±80.3 | 0.425 |
Total cholesterol (mg/dL) | 182.68±38 | 178.85±42.03 | 0.542 |
LDL-C (mg/dL) | 112.17±29.5 | 105.15±39.1 | 0.197 |
HDL-C (mg/dL) | 33.37±7.72 | 39.6±8.52 | <0.001 |
LVEF (%) | 57.57±6.7 | 57.13±8.6 | 0.983 |
Galectin-3 (ng/mL) | 12.96±4.9 | 5.52±1.9 | <0.001 |
Hs-CRP (mg/L) | 2.83±1.47 | 1.11±0.56 | <0.001 |
Gensini score | 63.37±23.9 (26–123) | | |
Number of diseased vessels |
0 | | 82 (100%) | |
1 | 37 (45.1%) | | |
2 | 30 (36.6%) | | |
3 | 15 (18.3%) | | |
Location of stenosis |
LMCA | 4 (4.9%) | | |
LAD | 51 (62.2%) | | |
LCx | 35 (42.7%) | | |
RCA | 41 (50%) | | |
Medical treatments |
ACE inhibitor/ARB, n (%) | 22 (26.8) | 19 (23.2) | 0.718 |
B-blocker, n (%) | 15 (18.3) | 11 (13.4) | 0.521 |
Statin, n (%) | 11 (13.4) | 9 (11) | 0.811 |
ASA | 21 (25.6) | 16 (19.5) | 0.231 |